BugInnoculator

    Phenotypic answers on your terms. Hours instead of days.

    Microbiologists know better than anyone: when it comes to antimicrobial susceptibility, phenotypic results remain the gold standard. BugInnoculator gives you a direct path to clean, viable isolates from whole blood, letting you run phenotypic ID and AST without waiting for the bottle to flag.

    Designed for microbiologists. Built around your workflow.

    The Challenge

    Blood culture remains essential, but its timing is a bottleneck. Waiting 1–5 days for growth means clinicians must treat blindly, and microbiologists must delay the tests they trust most. Across hospitals, this slows targeted therapy, increases broad-spectrum use, and burdens already-stretched teams.

    The BugInnoculator Advantage

    A direct, blood culture-independent route to viable isolates

    Hours, not days

    Generate ID- and AST-ready isolates in the same shift. Compress the timeline for actionable, phenotypic results.

    Phenotypic Freedom

    Run the tests you believe in — MALDI ID, rapid AST, growth-based methods — with organisms that behave as they should.

    Fits the bench, not the other way around

    The workflow complements your existing tools and routines. No specialised instruments. No disruption. Just more possibility.

    Why microbiologists are excited about BugInnoculator

    Because you want to see the bug — not the proxy

    True phenotypic AST captures expression, resistance mechanisms, and unexpected behaviours that molecular panels cannot anticipate.

    Because viability matters

    You get intact organisms, ready for real-world exposure testing, even in polymicrobial or low-load samples.

    Because every hour of clarity helps patients

    Earlier targeted therapy means better outcomes, fewer broad-spectrum defaults, and reduced hospital burden.

    Learn More About BugInnoculator

    Discover how BugInnoculator can transform your approach to bloodstream infection diagnostics.

    Supported through

    KTH InnovationDRIVe - BARDA Accelerator NetworkKnut and Alice Wallenberg FoundationBARDA SparkKTH Ventures